US Stock MarketDetailed Quotes

ELEV Elevation Oncology

Watchlist
  • 0.580
  • -0.046-7.30%
Close Dec 20 16:00 ET
  • 0.608
  • +0.028+4.83%
Post 19:58 ET
34.29MMarket Cap-0.73P/E (TTM)

Elevation Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
8.73%103.07M
2.71%110.85M
40.74%104.05M
-7.95%83.11M
-7.95%83.11M
-12.11%94.8M
-11.93%107.92M
-44.02%73.93M
-38.28%90.28M
-38.28%90.28M
-Cash and cash equivalents
-12.17%48.2M
-44.09%59.45M
62.12%90.63M
7.27%49.26M
7.27%49.26M
4.35%54.88M
97.33%106.33M
5.46%55.9M
-68.61%45.92M
-68.61%45.92M
-Short-term investments
37.45%54.87M
3,116.65%51.4M
-25.55%13.42M
-23.69%33.85M
-23.69%33.85M
-27.77%39.92M
-97.67%1.6M
-77.20%18.03M
--44.36M
--44.36M
Other current assets
-43.68%2.25M
81.09%2.72M
101.26%3.84M
80.09%4.86M
80.09%4.86M
80.59%4M
31.41%1.5M
-12.85%1.91M
-14.11%2.7M
-14.11%2.7M
Total current assets
6.61%105.32M
3.79%113.57M
42.27%107.89M
-5.39%87.96M
-5.39%87.96M
-10.24%98.8M
-11.53%109.43M
-43.51%75.84M
-37.78%92.98M
-37.78%92.98M
Non current assets
Net PPE
-42.65%39K
-42.31%45K
-44.32%49K
-39.80%59K
-39.80%59K
-37.04%68K
160.00%78K
158.82%88K
157.89%98K
157.89%98K
-Gross PPE
----
----
----
0.00%157K
0.00%157K
----
----
----
121.13%157K
121.13%157K
-Accumulated depreciation
----
----
----
-66.10%-98K
-66.10%-98K
----
----
----
-78.79%-59K
-78.79%-59K
Other non current assets
-15.32%940K
13.38%983K
5.13%1.03M
-1.66%1.07M
-1.66%1.07M
-15.27%1.11M
1,194.03%867K
3,800.00%975K
3,293.75%1.09M
3,293.75%1.09M
Total non current assets
-16.89%979K
8.78%1.03M
1.03%1.07M
-4.81%1.13M
-4.81%1.13M
-16.93%1.18M
874.23%945K
1,701.69%1.06M
1,591.43%1.18M
1,591.43%1.18M
Total assets
6.33%106.3M
3.83%114.6M
41.70%108.96M
-5.38%89.09M
-5.38%89.09M
-10.33%99.98M
-10.84%110.37M
-42.75%76.9M
-37.01%94.16M
-37.01%94.16M
Liabilities
Current liabilities
Payables
-27.72%2.63M
-93.44%344K
-89.24%435K
-92.03%507K
-92.03%507K
-35.75%3.64M
304.40%5.24M
358.39%4.04M
12.64%6.36M
12.64%6.36M
-accounts payable
-27.72%2.63M
-93.44%344K
-89.24%435K
-92.03%507K
-92.03%507K
-35.75%3.64M
304.40%5.24M
358.39%4.04M
12.64%6.36M
12.64%6.36M
Current accrued expenses
14.60%1.59M
6.51%1.34M
-85.55%1.27M
-81.78%1.25M
-81.78%1.25M
-81.83%1.38M
-92.45%1.26M
-2.20%8.79M
228.15%6.83M
228.15%6.83M
Current liabilities
-22.10%5.93M
-67.17%2.76M
-82.75%2.33M
-73.59%4.15M
-73.59%4.15M
-49.62%7.61M
-55.92%8.42M
29.70%13.53M
78.54%15.69M
78.54%15.69M
Non current liabilities
Long term debt and capital lease obligation
3.57%31.02M
3.84%30.92M
4.08%30.81M
2.38%30.14M
2.38%30.14M
2.34%29.95M
--29.77M
--29.6M
--29.44M
--29.44M
-Long term debt
3.57%31.02M
3.84%30.92M
4.08%30.81M
2.38%30.14M
2.38%30.14M
2.34%29.95M
--29.77M
--29.6M
--29.44M
--29.44M
Other non current liabilities
----
----
----
----
----
----
----
----
-75.00%2K
-75.00%2K
Total non current liabilities
3.57%31.02M
3.84%30.92M
4.08%30.81M
2.38%30.14M
2.38%30.14M
2.33%29.95M
595,340.00%29.77M
422,757.14%29.6M
367,862.50%29.44M
367,862.50%29.44M
Total liabilities
-1.63%36.95M
-11.81%33.68M
-23.16%33.14M
-24.04%34.28M
-24.04%34.28M
-15.35%37.56M
99.95%38.19M
313.08%43.13M
413.00%45.13M
413.00%45.13M
Shareholders'equity
Share capital
50.00%6K
25.00%5K
150.00%5K
100.00%4K
100.00%4K
100.00%4K
100.00%4K
0.00%2K
0.00%2K
0.00%2K
-common stock
50.00%6K
25.00%5K
150.00%5K
100.00%4K
100.00%4K
100.00%4K
100.00%4K
0.00%2K
0.00%2K
0.00%2K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-22.30%-230.02M
-22.38%-217.14M
-23.52%-206.68M
-30.42%-195.97M
-30.42%-195.97M
-43.32%-188.07M
-92.06%-177.44M
-130.92%-167.33M
-172.29%-150.27M
-172.29%-150.27M
Paid-in capital
19.48%299.34M
19.43%298.18M
40.46%282.58M
25.73%250.83M
25.73%250.83M
26.13%250.54M
26.50%249.67M
2.37%201.19M
1.84%199.49M
1.84%199.49M
Less: Treasury stock
80.70%103K
87.04%101K
80.85%85K
68.57%59K
68.57%59K
83.87%57K
116.00%54K
--47K
--35K
--35K
Gains losses not affecting retained earnings
12,900.00%128K
-1,200.00%-26K
--0
105.59%9K
105.59%9K
99.61%-1K
99.27%-2K
75.00%-51K
---161K
---161K
Total stockholders'equity
11.12%69.36M
12.10%80.92M
124.55%75.82M
11.78%54.81M
11.78%54.81M
-7.01%62.42M
-31.05%72.18M
-72.74%33.76M
-65.15%49.03M
-65.15%49.03M
Total equity
11.12%69.36M
12.10%80.92M
124.55%75.82M
11.78%54.81M
11.78%54.81M
-7.01%62.42M
-31.05%72.18M
-72.74%33.76M
-65.15%49.03M
-65.15%49.03M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments 8.73%103.07M2.71%110.85M40.74%104.05M-7.95%83.11M-7.95%83.11M-12.11%94.8M-11.93%107.92M-44.02%73.93M-38.28%90.28M-38.28%90.28M
-Cash and cash equivalents -12.17%48.2M-44.09%59.45M62.12%90.63M7.27%49.26M7.27%49.26M4.35%54.88M97.33%106.33M5.46%55.9M-68.61%45.92M-68.61%45.92M
-Short-term investments 37.45%54.87M3,116.65%51.4M-25.55%13.42M-23.69%33.85M-23.69%33.85M-27.77%39.92M-97.67%1.6M-77.20%18.03M--44.36M--44.36M
Other current assets -43.68%2.25M81.09%2.72M101.26%3.84M80.09%4.86M80.09%4.86M80.59%4M31.41%1.5M-12.85%1.91M-14.11%2.7M-14.11%2.7M
Total current assets 6.61%105.32M3.79%113.57M42.27%107.89M-5.39%87.96M-5.39%87.96M-10.24%98.8M-11.53%109.43M-43.51%75.84M-37.78%92.98M-37.78%92.98M
Non current assets
Net PPE -42.65%39K-42.31%45K-44.32%49K-39.80%59K-39.80%59K-37.04%68K160.00%78K158.82%88K157.89%98K157.89%98K
-Gross PPE ------------0.00%157K0.00%157K------------121.13%157K121.13%157K
-Accumulated depreciation -------------66.10%-98K-66.10%-98K-------------78.79%-59K-78.79%-59K
Other non current assets -15.32%940K13.38%983K5.13%1.03M-1.66%1.07M-1.66%1.07M-15.27%1.11M1,194.03%867K3,800.00%975K3,293.75%1.09M3,293.75%1.09M
Total non current assets -16.89%979K8.78%1.03M1.03%1.07M-4.81%1.13M-4.81%1.13M-16.93%1.18M874.23%945K1,701.69%1.06M1,591.43%1.18M1,591.43%1.18M
Total assets 6.33%106.3M3.83%114.6M41.70%108.96M-5.38%89.09M-5.38%89.09M-10.33%99.98M-10.84%110.37M-42.75%76.9M-37.01%94.16M-37.01%94.16M
Liabilities
Current liabilities
Payables -27.72%2.63M-93.44%344K-89.24%435K-92.03%507K-92.03%507K-35.75%3.64M304.40%5.24M358.39%4.04M12.64%6.36M12.64%6.36M
-accounts payable -27.72%2.63M-93.44%344K-89.24%435K-92.03%507K-92.03%507K-35.75%3.64M304.40%5.24M358.39%4.04M12.64%6.36M12.64%6.36M
Current accrued expenses 14.60%1.59M6.51%1.34M-85.55%1.27M-81.78%1.25M-81.78%1.25M-81.83%1.38M-92.45%1.26M-2.20%8.79M228.15%6.83M228.15%6.83M
Current liabilities -22.10%5.93M-67.17%2.76M-82.75%2.33M-73.59%4.15M-73.59%4.15M-49.62%7.61M-55.92%8.42M29.70%13.53M78.54%15.69M78.54%15.69M
Non current liabilities
Long term debt and capital lease obligation 3.57%31.02M3.84%30.92M4.08%30.81M2.38%30.14M2.38%30.14M2.34%29.95M--29.77M--29.6M--29.44M--29.44M
-Long term debt 3.57%31.02M3.84%30.92M4.08%30.81M2.38%30.14M2.38%30.14M2.34%29.95M--29.77M--29.6M--29.44M--29.44M
Other non current liabilities ---------------------------------75.00%2K-75.00%2K
Total non current liabilities 3.57%31.02M3.84%30.92M4.08%30.81M2.38%30.14M2.38%30.14M2.33%29.95M595,340.00%29.77M422,757.14%29.6M367,862.50%29.44M367,862.50%29.44M
Total liabilities -1.63%36.95M-11.81%33.68M-23.16%33.14M-24.04%34.28M-24.04%34.28M-15.35%37.56M99.95%38.19M313.08%43.13M413.00%45.13M413.00%45.13M
Shareholders'equity
Share capital 50.00%6K25.00%5K150.00%5K100.00%4K100.00%4K100.00%4K100.00%4K0.00%2K0.00%2K0.00%2K
-common stock 50.00%6K25.00%5K150.00%5K100.00%4K100.00%4K100.00%4K100.00%4K0.00%2K0.00%2K0.00%2K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -22.30%-230.02M-22.38%-217.14M-23.52%-206.68M-30.42%-195.97M-30.42%-195.97M-43.32%-188.07M-92.06%-177.44M-130.92%-167.33M-172.29%-150.27M-172.29%-150.27M
Paid-in capital 19.48%299.34M19.43%298.18M40.46%282.58M25.73%250.83M25.73%250.83M26.13%250.54M26.50%249.67M2.37%201.19M1.84%199.49M1.84%199.49M
Less: Treasury stock 80.70%103K87.04%101K80.85%85K68.57%59K68.57%59K83.87%57K116.00%54K--47K--35K--35K
Gains losses not affecting retained earnings 12,900.00%128K-1,200.00%-26K--0105.59%9K105.59%9K99.61%-1K99.27%-2K75.00%-51K---161K---161K
Total stockholders'equity 11.12%69.36M12.10%80.92M124.55%75.82M11.78%54.81M11.78%54.81M-7.01%62.42M-31.05%72.18M-72.74%33.76M-65.15%49.03M-65.15%49.03M
Total equity 11.12%69.36M12.10%80.92M124.55%75.82M11.78%54.81M11.78%54.81M-7.01%62.42M-31.05%72.18M-72.74%33.76M-65.15%49.03M-65.15%49.03M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List